London · Delayed Price · Currency is GBP · Price in GBX Ilika Earnings Call Transcripts
Fiscal Year 2026
-
Solid-state battery commercialization advanced with first Stereax revenues and strong Goliath prototype validation. Revenue held steady at £1.1M, EBITDA loss widened due to scale-up, and new funding supports growth. Early non-automotive deals and robust partnerships drive near-term momentum.
-
Stereax achieved first commercial deliveries and began generating revenue, while Goliath shipped 10Ah prototypes and opened licensing discussions. Turnover declined to £0.6M due to grant timing, but cash remains strong. Key 2026 milestones include Stereax integration and Goliath customer feedback.
Fiscal Year 2025
-
Solid-state battery developer reported FY revenue of GBP 1.1 million, down year-on-year due to grant timing, but expects Stereax production and revenue in 2025 and strong Goliath prototype validation. Cash reserves exceed GBP 11 million after a successful fundraise.
-
Solid-state battery developer advances Stereax and Goliath product lines, with Stereax entering commercial production via Cirtec and Goliath achieving key prototype milestones. A GBP 3.5 million capital raise will support commercialization, with strong industry partnerships and a robust patent portfolio.
-
Stereax production is set to begin in 2025 with initial revenues expected mid-year, while Goliath batteries advance through key technical milestones and licensing discussions. Cash burn is well managed, and grant funding continues to support scale-up, but revenue growth depends on successful commercialization and customer adoption.
Fiscal Year 2024
-
Asset-light licensing model drives growth in solid-state battery tech for medical and EV markets, with revenue set to begin in 2025. Financials show strong grant-driven turnover, reduced losses, and extended cash runway. Key milestones include Cirtec partnership and Goliath prototype shipments.